The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target

Galectin-3 is the most studied member of the Galectin family, with a large range of mediation in biological activities such as cell growth, proliferation, apoptosis, differentiation, cell adhesion, and tissue repair, as well as in pathological processes such as inflammation, tissue fibrosis, and ang...

Full description

Bibliographic Details
Main Authors: Ziyi Zhou, Zhaochen Feng, Xiaojia Sun, Yusheng Wang, Guorui Dou
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/21/15516
_version_ 1797631869855989760
author Ziyi Zhou
Zhaochen Feng
Xiaojia Sun
Yusheng Wang
Guorui Dou
author_facet Ziyi Zhou
Zhaochen Feng
Xiaojia Sun
Yusheng Wang
Guorui Dou
author_sort Ziyi Zhou
collection DOAJ
description Galectin-3 is the most studied member of the Galectin family, with a large range of mediation in biological activities such as cell growth, proliferation, apoptosis, differentiation, cell adhesion, and tissue repair, as well as in pathological processes such as inflammation, tissue fibrosis, and angiogenesis. As is known to all, inflammation, aberrant cell apoptosis, and neovascularization are the main pathophysiological processes in retinal degeneration and many ocular diseases. Therefore, the review aims to conclude the role of Gal3 in the retinal degeneration of various diseases as well as the occurrence and development of the diseases and discuss its molecular mechanisms according to research in systemic diseases. At the same time, we summarized the predictive role of Gal3 as a biomarker and the clinical application of its inhibitors to discuss the possibility of Gal3 as a novel target for the treatment of ocular diseases.
first_indexed 2024-03-11T11:29:51Z
format Article
id doaj.art-85f14c891d7c41ec86fa0df127b6f9ac
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T11:29:51Z
publishDate 2023-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-85f14c891d7c41ec86fa0df127b6f9ac2023-11-10T15:04:14ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-10-0124211551610.3390/ijms242115516The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic TargetZiyi Zhou0Zhaochen Feng1Xiaojia Sun2Yusheng Wang3Guorui Dou4Department of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaDepartment of Ophthalmology, Eye Institute of Chinese PLA, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, ChinaGalectin-3 is the most studied member of the Galectin family, with a large range of mediation in biological activities such as cell growth, proliferation, apoptosis, differentiation, cell adhesion, and tissue repair, as well as in pathological processes such as inflammation, tissue fibrosis, and angiogenesis. As is known to all, inflammation, aberrant cell apoptosis, and neovascularization are the main pathophysiological processes in retinal degeneration and many ocular diseases. Therefore, the review aims to conclude the role of Gal3 in the retinal degeneration of various diseases as well as the occurrence and development of the diseases and discuss its molecular mechanisms according to research in systemic diseases. At the same time, we summarized the predictive role of Gal3 as a biomarker and the clinical application of its inhibitors to discuss the possibility of Gal3 as a novel target for the treatment of ocular diseases.https://www.mdpi.com/1422-0067/24/21/15516galectin-3retinal degenerationmolecular mechanismsdiagnosticsmolecular therapy
spellingShingle Ziyi Zhou
Zhaochen Feng
Xiaojia Sun
Yusheng Wang
Guorui Dou
The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target
International Journal of Molecular Sciences
galectin-3
retinal degeneration
molecular mechanisms
diagnostics
molecular therapy
title The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target
title_full The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target
title_fullStr The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target
title_full_unstemmed The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target
title_short The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target
title_sort role of galectin 3 in retinal degeneration and other ocular diseases a potential novel biomarker and therapeutic target
topic galectin-3
retinal degeneration
molecular mechanisms
diagnostics
molecular therapy
url https://www.mdpi.com/1422-0067/24/21/15516
work_keys_str_mv AT ziyizhou theroleofgalectin3inretinaldegenerationandotheroculardiseasesapotentialnovelbiomarkerandtherapeutictarget
AT zhaochenfeng theroleofgalectin3inretinaldegenerationandotheroculardiseasesapotentialnovelbiomarkerandtherapeutictarget
AT xiaojiasun theroleofgalectin3inretinaldegenerationandotheroculardiseasesapotentialnovelbiomarkerandtherapeutictarget
AT yushengwang theroleofgalectin3inretinaldegenerationandotheroculardiseasesapotentialnovelbiomarkerandtherapeutictarget
AT guoruidou theroleofgalectin3inretinaldegenerationandotheroculardiseasesapotentialnovelbiomarkerandtherapeutictarget
AT ziyizhou roleofgalectin3inretinaldegenerationandotheroculardiseasesapotentialnovelbiomarkerandtherapeutictarget
AT zhaochenfeng roleofgalectin3inretinaldegenerationandotheroculardiseasesapotentialnovelbiomarkerandtherapeutictarget
AT xiaojiasun roleofgalectin3inretinaldegenerationandotheroculardiseasesapotentialnovelbiomarkerandtherapeutictarget
AT yushengwang roleofgalectin3inretinaldegenerationandotheroculardiseasesapotentialnovelbiomarkerandtherapeutictarget
AT guoruidou roleofgalectin3inretinaldegenerationandotheroculardiseasesapotentialnovelbiomarkerandtherapeutictarget